Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05149573 · ClinicalTrials.gov registry record · NA
Investigation of PEMF Therapy for Female Patients With IC/BPS
A NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT05149573: Recruiting NA study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Wake Forest University Health Sciences.
NCT05149573 is a NA study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 75 participants, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05149573, a NA study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.
Primary Outcome
The BPI Short Form is a validated questionnaire to assess the severity of systemic and pelvic pain and its interference in overall quality of life. Pain severity is measured through four 11-point numeric rating scales (NRS) assessing pain at its "worst," "least," and "average," within the past week, and pain "right now" (at the time of short form completion), with the composite (mean score) of all four scales indicating overall pelvic pain. Pain interference is measured through 7 scales, with sc
Conditions Studied
Interventions
- DEVICE Pulsed Electromagnetic Field (PEMF) Device
- DEVICE Sham Pulsed Electromagnetic Field (PEMF) Device
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-08-29 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT05149573 shows while recruiting
NCT05149573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 359-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (79% lower).
The record links to 3 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Pulsed Electromagnetic Field (PEMF) Device is the first listed.
NCT05149573 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05149573 about?
NCT05149573 is a clinical study titled "Investigation of PEMF Therapy for Female Patients With IC/BPS". The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cy...
What is the current status of trial NCT05149573?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-08-29. Estimated completion is 2026-04.
What conditions does trial NCT05149573 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome, Chronic Interstitial Cystitis.
What interventions are being tested in trial NCT05149573?
The interventions under investigation include: Pulsed Electromagnetic Field (PEMF) Device (DEVICE), Sham Pulsed Electromagnetic Field (PEMF) Device (DEVICE).
Who is sponsoring clinical trial NCT05149573?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05149573 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05149573's enrollment target sits among peer trials
75 16th of 26 higher than 11 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Acupuncture First for IC/BPS
RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
ACTIVE NOT RECRUITING · NA
-
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI